Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2000 | 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Sales | 14,531 | 12,845 | 12,127 | 12,550 | 4,968 |
| Cost of Goods | 6,687 | 5,790 | 6,050 | 7,680 | 2,690 |
| Gross Profit | 7,844 | 7,070 | 6,070 | 4,860 | 2,270 |
| Operating Expenses | 9,753 | 9,200 | 8,810 | 10,360 | 6,480 |
| Operating Income | -1,222 | -1,355 | -2,683 | -4,810 | -3,512 |
| Interest Expense | 0 | 500 | 210 | 0 | 0 |
| Other Income | 249 | 585 | 323 | -10 | 4,392 |
| Pre-tax Income | -973 | -1,270 | -2,570 | -4,820 | 880 |
| Income Tax | 62 | -490 | -540 | -1,240 | 460 |
| Net Income Continuous | -1,035 | -781 | -2,029 | -3,582 | 426 |
| Net Income | $-1,505 | $-781 | $-2,029 | $-3,582 | $426 |
| EPS Basic Total Ops | -0.18 | -0.03 | -0.07 | -0.12 | 0.01 |
| EPS Basic Continuous Ops | -0.16 | -0.02 | -0.06 | -0.11 | 0.01 |
| EPS Diluted Total Ops | -0.18 | -0.03 | -0.07 | -0.12 | 0.01 |
| EPS Diluted Continuous Ops | -0.16 | -0.02 | -0.06 | -0.11 | 0.01 |
| EBITDA(a) | $-140 | $-685 | $-253 | $-5,300 | $-3,022 |